82 related articles for article (PubMed ID: 24088706)
1. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
[TBL] [Abstract][Full Text] [Related]
2. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
Nancarrow DJ; Clouston AD; Smithers BM; Gotley DC; Drew PA; Watson DI; Tyagi S; Hayward NK; Whiteman DC; ;
PLoS One; 2011; 6(7):e22513. PubMed ID: 21829465
[TBL] [Abstract][Full Text] [Related]
3.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma.
Wu W; Bhagat TD; Yang X; Song JH; Cheng Y; Agarwal R; Abraham JM; Ibrahim S; Bartenstein M; Hussain Z; Suzuki M; Yu Y; Chen W; Eng C; Greally J; Verma A; Meltzer SJ
Gastroenterology; 2013 May; 144(5):956-966.e4. PubMed ID: 23333711
[TBL] [Abstract][Full Text] [Related]
5. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
[TBL] [Abstract][Full Text] [Related]
6. GATA4 blocks squamous epithelial cell gene expression in human esophageal squamous cells.
Stavniichuk R; DeLaForest A; Thompson CA; Miller J; Souza RF; Battle MA
Sci Rep; 2021 Feb; 11(1):3206. PubMed ID: 33547361
[TBL] [Abstract][Full Text] [Related]
7. Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.
Moinova H; Leidner RS; Ravi L; Lutterbaugh J; Barnholtz-Sloan JS; Chen Y; Chak A; Markowitz SD; Willis JE
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):594-600. PubMed ID: 22315367
[TBL] [Abstract][Full Text] [Related]
8. Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation.
Bultmann I; Conradi A; Kretschmer C; Sterner-Kock A
PLoS One; 2013; 8(5):e65614. PubMed ID: 23741501
[TBL] [Abstract][Full Text] [Related]
9. AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas.
Ghosh P; Campos VJ; Vo DT; Guccione C; Goheen-Holland V; Tindle C; Mazzini GS; He Y; Alexandrov LB; Lippman SM; Gurski RR; Das S; Yadlapati R; Curtius K; Sahoo D
JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134663
[TBL] [Abstract][Full Text] [Related]
10. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.
Frankell AM; Jammula S; Li X; Contino G; Killcoyne S; Abbas S; Perner J; Bower L; Devonshire G; Ococks E; Grehan N; Mok J; O'Donovan M; MacRae S; Eldridge MD; Tavaré S; ; Fitzgerald RC
Nat Genet; 2019 Mar; 51(3):506-516. PubMed ID: 30718927
[TBL] [Abstract][Full Text] [Related]
11. MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients.
Zheng R; Yao B; Ye Y; Luo R; Wu Z; Hu X; Yuan Y; Pan X; Liu C; Huang L; Luo Y; Yang D; Shang N; Tian Y; Jia J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):248-254. PubMed ID: 38678596
[TBL] [Abstract][Full Text] [Related]
12. Research advances of MAL family members in tumorigenesis and tumor progression (Review).
Li M; Du Y; Zhang X; Zhou W
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38362940
[TBL] [Abstract][Full Text] [Related]
13. The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.
Labat-de-Hoz L; Rubio-Ramos A; Correas I; Alonso MA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345137
[TBL] [Abstract][Full Text] [Related]
14. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.
Han Y; Ji L; Guan Y; Ma M; Li P; Xue Y; Zhang Y; Huang W; Gong Y; Jiang L; Wang X; Xie H; Zhou B; Wang J; Wang J; Han J; Deng Y; Yi X; Gao F; Huang J
Clin Transl Med; 2021 Jul; 11(7):e498. PubMed ID: 34323415
[TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer.
Wang W; Liao K; Guo HC; Zhou S; Yu R; Liu Y; Pan Y; Pu J
J Cardiothorac Surg; 2021 May; 16(1):148. PubMed ID: 34044866
[TBL] [Abstract][Full Text] [Related]
16. The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.
Rubio-Ramos A; Labat-de-Hoz L; Correas I; Alonso MA
Cells; 2021 Apr; 10(5):. PubMed ID: 33946345
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths.
Dai Y; Wang Q; Gonzalez Lopez A; Anders M; Malfertheiner P; Vieth M; Kemmner W
Transl Oncol; 2018 Feb; 11(1):116-124. PubMed ID: 29223109
[TBL] [Abstract][Full Text] [Related]
18. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
